Current therapeutic options for giant cell arteritis;Aktuelle Therapieansätze bei Riesenzellarteriitis

Zeitschrift fur Rheumatologie

Volumn 68, Issue 2, 2009, Pages 132-136

  Wipfler Freissmuth E ^a   Loock, J ^b   Moosig, F ^b   Dejaco, C ^a   Duftner, C ^a   Schirmer, M ^a  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Giant cell arteritis; Methotrexate; Therapy; TNF alpha inhibitors; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTERY DIAMETER; CLINICAL TRIAL; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG EFFICACY; GIANT CELL ARTERITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; REVIEW; STEROID THERAPY; SYSTEMIC VASCULITIS;

ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; GIANT CELL ARTERITIS; GLUCOCORTICOIDS; HUMANS; RHEUMATOLOGY;

EID: 62449178150     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-008-0378-2     Document Type: Review

References (25)

1. Bhatia 2005 Ann Rheum Dis 64 1099
2. Cantini 2001 Arthritis Rheum 44 2933
3. Chevalet 2000 J Rheumatol 27 1484
4. De 1986 Arthritis Rheum 45 136
5. De 1992 J Interne Med 232 373
6. Field 1997 Rheumatol Int 17 113
7. Hayreh 2003 Ophthalmologica 217 239
8. Hernandez-Rodrigues J, Segarra M, Vilardell C et al (2004) Tissue production of pro-inflammatory cytokines (IL-1ß, TNF-α and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant cell arteritis. Rheumatololy (Oxford) 43:294-301
9. Hoffman 2007 Ann Intern Med 146 621
10. Hoffmann 2002 Arthritis Rheum 46 1309
11. Jover 2001 Ann Intern Med 134 106
12. Le Guennec P, Dromer C, Sixou L et al (1994) Treatment of Horton's disease. Value of synthetic antimalarials. Apropos of a retrospective study of 36 patients. Rheum (Engl Ed) 61:485-490
13. Lee 2006 Arthritis Rheum 54 3306
14. Mahr 2007 Arthritis Rheum 56 2789
15. Martínez-Taboada 2008 Ann Rheum Dis 67 625
16. Mazlumzadeh 2006 Arthritis Rheum 54 3310
17. Mubashir 2007 Clin Rheumatol 26 1353
18. Mukhtyar C, Guillevin L, Cid MC et al (2008) EULAR Recommendations for the management of large vessel vasculitis. Ann Rheum Dis [Epub ahead of print]
19. Nesher 2004 Arthritis Rheum 50 1332
20. Proven 2003 Arthritis Rheum 49 703
21. Roblet 1998 Ann Med Interne 441
22. Salvarani 2008 Ann Rheum Dis 67 577
23. Schaufelberger 2006 Scand J Rheumatol 35 327
24. Spiera RF, Mitnick HJ, Kupersmith M et al (2001) A prospective, double-blind, randomized, placebo-controlled trial of methotrexate in the treatment of giant cell arteritis (GCA) Clin Exp Rheumatol 19:495-501
25. Weyand 2000 Arthritis Rheum 43 1041